Virax Biolabs Group Ltd (VRAX)
1.94
+0.01
(+0.52%)
USD |
NASDAQ |
Sep 27, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Virax Biolabs Group Total Liabilities (Quarterly): 0.3452M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.3452M |
| September 30, 2023 | 0.919M |
| September 30, 2023 | 0.919M |
| March 31, 2023 | 0.9084M |
| September 30, 2022 | 1.142M |
| Date | Value |
|---|---|
| September 30, 2022 | 1.142M |
| March 31, 2022 | 1.245M |
| September 30, 2021 | 1.046M |
| September 30, 2021 | 1.046M |
| March 31, 2021 | 0.8714M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3452M
Minimum
Mar 2024
1.245M
Maximum
Mar 2022
0.9585M
Average
0.9823M
Median
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 225.43M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 265.85M |
| NuCana PLC | 20.58M |
| Autolus Therapeutics PLC | 325.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.484M |
| Shareholders Equity (Quarterly) | 5.367M |
| Current Ratio | 25.94 |
| Net Debt Paydown Yield | 7.04% |